ID   PACE1_HUMAN             Reviewed;         742 AA.
AC   Q8IZE3; A8K8Z2; Q5THA6; Q5THA8; Q8IZN9; Q96C56; Q9UBK6;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-OCT-2022, entry version 174.
DE   RecName: Full=Protein-associating with the carboxyl-terminal domain of ezrin;
DE   AltName: Full=Ezrin-binding protein PACE-1;
DE   AltName: Full=SCY1-like protein 3;
GN   Name=SCYL3; Synonyms=PACE1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, INTERACTION WITH
RP   EZR, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, PHOSPHORYLATION,
RP   MYRISTOYLATION AT GLY-2, MUTAGENESIS OF 2-GLU--SER-6, AND VARIANT ARG-621.
RC   TISSUE=Kidney;
RX   PubMed=12651155; DOI=10.1016/s0014-4827(02)00054-x;
RA   Sullivan A., Uff C.R., Isacke C.M., Thorne R.F.;
RT   "PACE-1, a novel protein that interacts with the C-terminal domain of
RT   ezrin.";
RL   Exp. Cell Res. 284:224-238(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Rhodes S., Huckle E.;
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ARG-621.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-621.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT ALA-597.
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-707, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May play a role in regulating cell adhesion/migration
CC       complexes in migrating cells. {ECO:0000269|PubMed:12651155}.
CC   -!- SUBUNIT: Interacts with EZR/VIL2 C-terminal domain.
CC       {ECO:0000269|PubMed:12651155}.
CC   -!- INTERACTION:
CC       Q8IZE3; P15311: EZR; NbExp=5; IntAct=EBI-1380680, EBI-1056902;
CC       Q8IZE3; Q9H0R8: GABARAPL1; NbExp=3; IntAct=EBI-1380680, EBI-746969;
CC       Q8IZE3; Q68G74: LHX8; NbExp=3; IntAct=EBI-1380680, EBI-8474075;
CC       Q8IZE3; Q99757: TXN2; NbExp=4; IntAct=EBI-1380680, EBI-2932492;
CC       Q8IZE3-2; Q9H0R8: GABARAPL1; NbExp=3; IntAct=EBI-11959369, EBI-746969;
CC       Q8IZE3-2; P60520: GABARAPL2; NbExp=3; IntAct=EBI-11959369, EBI-720116;
CC       Q8IZE3-2; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-11959369, EBI-1055254;
CC       Q8IZE3-2; Q9Y4C2-2: TCAF1; NbExp=3; IntAct=EBI-11959369, EBI-11974855;
CC       Q8IZE3-2; Q99757: TXN2; NbExp=3; IntAct=EBI-11959369, EBI-2932492;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12651155}. Golgi
CC       apparatus {ECO:0000269|PubMed:12651155}. Cell projection, lamellipodium
CC       {ECO:0000269|PubMed:12651155}. Note=Colocalized with EZR/VIL2, actin
CC       and CD44 in lamellipodia.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IZE3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IZE3-2; Sequence=VSP_013125;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:12651155}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- PTM: May be myristoylated; myristoylation may target it to Golgi
CC       compartment. {ECO:0000269|PubMed:12651155}.
CC   -!- PTM: Phosphorylated. {ECO:0000269|PubMed:12651155}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF540957; AAN23123.1; -; mRNA.
DR   EMBL; AY144493; AAN41656.1; -; mRNA.
DR   EMBL; AL117233; CAB55300.1; -; mRNA.
DR   EMBL; AK292507; BAF85196.1; -; mRNA.
DR   EMBL; AL031297; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW90867.1; -; Genomic_DNA.
DR   EMBL; BC014662; AAH14662.1; -; mRNA.
DR   CCDS; CCDS1286.1; -. [Q8IZE3-2]
DR   CCDS; CCDS1287.1; -. [Q8IZE3-1]
DR   RefSeq; NP_065156.5; NM_020423.6. [Q8IZE3-2]
DR   RefSeq; NP_851607.2; NM_181093.3. [Q8IZE3-1]
DR   RefSeq; XP_006711528.1; XM_006711465.1. [Q8IZE3-1]
DR   RefSeq; XP_011508103.1; XM_011509801.1. [Q8IZE3-1]
DR   RefSeq; XP_016857351.1; XM_017001862.1. [Q8IZE3-2]
DR   RefSeq; XP_016857352.1; XM_017001863.1. [Q8IZE3-2]
DR   AlphaFoldDB; Q8IZE3; -.
DR   SMR; Q8IZE3; -.
DR   BioGRID; 121404; 95.
DR   IntAct; Q8IZE3; 34.
DR   MINT; Q8IZE3; -.
DR   STRING; 9606.ENSP00000356746; -.
DR   GlyGen; Q8IZE3; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8IZE3; -.
DR   PhosphoSitePlus; Q8IZE3; -.
DR   BioMuta; SCYL3; -.
DR   DMDM; 61214481; -.
DR   EPD; Q8IZE3; -.
DR   jPOST; Q8IZE3; -.
DR   MassIVE; Q8IZE3; -.
DR   MaxQB; Q8IZE3; -.
DR   PaxDb; Q8IZE3; -.
DR   PeptideAtlas; Q8IZE3; -.
DR   PRIDE; Q8IZE3; -.
DR   ProteomicsDB; 71333; -. [Q8IZE3-1]
DR   ProteomicsDB; 71334; -. [Q8IZE3-2]
DR   Antibodypedia; 936; 252 antibodies from 23 providers.
DR   DNASU; 57147; -.
DR   Ensembl; ENST00000367770.5; ENSP00000356744.1; ENSG00000000457.14. [Q8IZE3-1]
DR   Ensembl; ENST00000367771.11; ENSP00000356745.5; ENSG00000000457.14. [Q8IZE3-2]
DR   Ensembl; ENST00000367772.8; ENSP00000356746.4; ENSG00000000457.14. [Q8IZE3-1]
DR   GeneID; 57147; -.
DR   KEGG; hsa:57147; -.
DR   MANE-Select; ENST00000367771.11; ENSP00000356745.5; NM_020423.7; NP_065156.5. [Q8IZE3-2]
DR   UCSC; uc001ggs.5; human. [Q8IZE3-1]
DR   CTD; 57147; -.
DR   DisGeNET; 57147; -.
DR   GeneCards; SCYL3; -.
DR   HGNC; HGNC:19285; SCYL3.
DR   HPA; ENSG00000000457; Low tissue specificity.
DR   MIM; 608192; gene.
DR   neXtProt; NX_Q8IZE3; -.
DR   OpenTargets; ENSG00000000457; -.
DR   PharmGKB; PA142670945; -.
DR   VEuPathDB; HostDB:ENSG00000000457; -.
DR   eggNOG; KOG1243; Eukaryota.
DR   GeneTree; ENSGT00930000151043; -.
DR   InParanoid; Q8IZE3; -.
DR   OMA; PQKNGGI; -.
DR   OrthoDB; 1074965at2759; -.
DR   PhylomeDB; Q8IZE3; -.
DR   TreeFam; TF313435; -.
DR   PathwayCommons; Q8IZE3; -.
DR   SignaLink; Q8IZE3; -.
DR   BioGRID-ORCS; 57147; 21 hits in 1113 CRISPR screens.
DR   ChiTaRS; SCYL3; human.
DR   GeneWiki; SCYL3; -.
DR   GenomeRNAi; 57147; -.
DR   Pharos; Q8IZE3; Tbio.
DR   PRO; PR:Q8IZE3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q8IZE3; protein.
DR   Bgee; ENSG00000000457; Expressed in buccal mucosa cell and 191 other tissues.
DR   ExpressionAtlas; Q8IZE3; baseline and differential.
DR   Genevisible; Q8IZE3; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:Ensembl.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; NAS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0008104; P:protein localization; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR021133; HEAT_type_2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50077; HEAT_REPEAT; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Cytoplasm; Golgi apparatus;
KW   Lipoprotein; Myristate; Phosphoprotein; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..742
FT                   /note="Protein-associating with the carboxyl-terminal
FT                   domain of ezrin"
FT                   /id="PRO_0000058167"
FT   DOMAIN          2..245
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REPEAT          199..238
FT                   /note="HEAT 1"
FT   REPEAT          285..323
FT                   /note="HEAT 2"
FT   REPEAT          333..370
FT                   /note="HEAT 3"
FT   REPEAT          372..409
FT                   /note="HEAT 4"
FT   REGION          506..544
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          548..742
FT                   /note="Interaction with EZR"
FT                   /evidence="ECO:0000269|PubMed:12651155"
FT   REGION          568..598
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          629..652
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          723..742
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        724..742
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         439
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBQ7"
FT   MOD_RES         707
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000305|PubMed:12651155"
FT   VAR_SEQ         438..491
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12651155,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2"
FT                   /id="VSP_013125"
FT   VARIANT         597
FT                   /note="G -> A (in dbSNP:rs12143301)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_051690"
FT   VARIANT         621
FT                   /note="Q -> R (in dbSNP:rs4656197)"
FT                   /evidence="ECO:0000269|PubMed:12651155,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|Ref.5"
FT                   /id="VAR_051691"
FT   MUTAGEN         2..6
FT                   /note="GSENS->M: No Golgi targeting, accumulates in the
FT                   cytoplasm."
FT                   /evidence="ECO:0000269|PubMed:12651155"
FT   CONFLICT        613
FT                   /note="M -> T (in Ref. 1; AAN23123/AAN41656)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   742 AA;  82857 MW;  2F7D03681A4F641B CRC64;
     MGSENSALKS YTLREPPFTL PSGLAVYPAV LQDGKFASVF VYKRENEDKV NKAAKHLKTL
     RHPCLLRFLS CTVEADGIHL VTERVQPLEV ALETLSSAEV CAGIYDILLA LIFLHDRGHL
     THNNVCLSSV FVSEDGHWKL GGMETVCKVS QATPEFLRSI QSIRDPASIP PEEMSPEFTT
     LPECHGHARD AFSFGTLVES LLTILNEQVS ADVLSSFQQT LHSTLLNPIP KCRPALCTLL
     SHDFFRNDFL EVVNFLKSLT LKSEEEKTEF FKFLLDRVSC LSEELIASRL VPLLLNQLVF
     AEPVAVKSFL PYLLGPKKDH AQGETPCLLS PALFQSRVIP VLLQLFEVHE EHVRMVLLSH
     IEAYVEHFTQ EQLKKVILPQ VLLGLRDTSD SIVAITLHSL AVLVSLLGPE VVVGGERTKI
     FKRTAPSFTK NTDLSLEDSP MCVVCSHHSQ ISPILENPFS SIFPKCFFSG STPINSKKHI
     QRDYYNTLLQ TGDPFSQPIK FPINGLSDVK NTSEDSENFP SSSKKSEEWP DWSEPEEPEN
     QTVNIQIWPR EPCDDVKSQC TTLDVEESSW DDCEPSSLDT KVNPGGGITA TKPVTSGEQK
     PIPALLSLTE ESMPWKSSLP QKISLVQRGD DADQIEPPKV SSQERPLKVP SELGLGEEFT
     IQVKKKPVKD PEMDWFADMI PEIKPSAAFL ILPELRTEMV PKKDDVSPVM QFSSKFAAAE
     ITEGEAEGWE EEGELNWEDN NW
//
